ESMO 2021: Drug combination shows promise in treatment-resistant advanced ovarian cancer 19 Sep 2021 A new combination of targeted drugs for a type of ovarian cancer has shown promising results in an early clinical trial – shrinking tumours in half of patients. Find out more Show/Hide